Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331
ETV6
淋巴细胞白血病
运行x1
白血病
作者
Leonard A. Mattano,Meenakshi Devidas,Kelly W. Maloney,Cindy Wang,Alison M. Friedmann,Patrick J. Buckley,Michael J. Borowitz,Andrew J. Carroll,Julie M. Gastier-Foster,Nyla A. Heerema,Nina S. Kadan-Lottick,Yousif Matloub,David T. Marshall,Linda C. Stork,Mignon L. Loh,Elizabeth A. Raetz,Brent L. Wood,Stephen P. Hunger,William L. Carroll,Naomi J. Winick
出处
期刊:Journal of Clinical Oncology [American Society of Clinical Oncology] 日期:2021-03-19卷期号:39 (14): 1540-1552被引量:3
标识
DOI:10.1200/jco.20.02370
摘要
PURPOSEChildren's Oncology Group (COG) AALL0331 tested whether pegaspargase intensification on a low-intensity chemotherapy backbone would improve the continuous complete remission (CCR) rate in a ...